After percutaneous coronary catheterisation (PCCC), how is the arterial puncture closed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Arterial Puncture Closure After Percutaneous Coronary Catheterization

After percutaneous coronary catheterization, the arterial puncture can be closed using either manual compression (the traditional gold standard) or arterial closure devices (ACDs), with the choice depending on procedural complexity and patient risk factors 1.

Primary Closure Methods

Manual Compression

  • Direct pressure applied to the puncture site for 15-52 minutes until hemostasis is achieved
  • Requires prolonged bed rest (typically 18-22 hours for diagnostic procedures)
  • Remains a safe, effective standard with complication rates of 0.4-1% in diagnostic procedures 1

Arterial Closure Devices (ACDs)

ACDs are categorized into three main types 1:

Active-Closure Devices:

  1. Collagen-mediated devices (e.g., Angio-Seal)

    • Most widely used ACD
    • Achieves hemostasis in 2.5-5 minutes vs. 15-52 minutes with manual compression
    • Reduces bed rest time from 952 to 438 minutes
    • Complication rates: 6% vs. 18% with manual compression in moderate-to-high-risk PCI patients 1

  2. Suture-mediated devices (e.g., Perclose)

    • Uses percutaneous sutures to close the arteriotomy
    • Achieves hemostasis in 8 minutes vs. 13 minutes with manual compression
    • Allows ambulation in 5 hours vs. 18 hours
    • Comparable vascular complication rates to manual compression 1

  3. Clip/staple-mediated devices (e.g., StarClose)

    • Uses flexible nitinol clip for circumferential extravascular closure
    • Reduces time to hemostasis from 15.5 to 1.5 minutes
    • 94% successful deployment rate
    • No significant difference in major vascular complications vs. manual compression 1

Passive-Closure Devices:

  • Include compression clamps (FemoStop), coagulant patches (D-Stat), and sealants
  • Generally less effective than active devices
  • D-Stat associated with higher vascular complications (7.1% vs. 1.9%) compared to active devices 1

Evidence-Based Recommendations

For diagnostic catheterization (low-risk patients):

  • Either manual compression or ACDs are acceptable
  • ACDs reduce time to hemostasis and ambulation without increasing complications
  • Expected complication rate: <1% with either method 1

For percutaneous coronary intervention (PCI):

  • ACDs are preferred over manual compression, particularly Angio-Seal or Perclose
  • Registry data from 166,680 procedures shows ACDs reduce vascular complications in men and after diagnostic procedures 1
  • Recent retrospective analysis of 9,108 procedures found VCD complication rate of 0.64% vs. 1.24% with manual compression (p=0.004) 2

Critical Caveats

Device failure considerations:

  • VCD deployment fails in approximately 1.23% of cases
  • Failed deployment increases complication risk to 10% 2
  • When VCD fails, revert immediately to manual compression

Patient-specific risk factors for complications:

  • Older age
  • Female sex
  • Large sheath size (7F-8F)
  • Body surface area
  • Concomitant antiplatelet therapy (especially abciximab/glycoprotein IIb/IIIa inhibitors) 1, 3

Important nuance: While meta-analyses show conflicting data on overall vascular complications (some showing OR 1.34 for increased complications with ACDs, others showing OR 0.89 for decreased complications), the most recent large-scale registry data and contemporary studies favor ACDs for faster hemostasis and reduced complications when properly deployed 1, 2.

Practical Algorithm

  1. Assess sheath size and procedure type

    • Small sheath (5F) diagnostic: Either method acceptable
    • Larger sheath (6-8F) or PCI: Prefer ACDs

  2. Evaluate patient risk factors

    • High-risk (elderly, female, large sheath, anticoagulation): Consider Angio-Seal or Perclose over manual compression
    • Low-risk: Either method acceptable

  3. If using ACD:

    • Confirm successful deployment
    • If deployment fails, immediately apply manual compression
    • Monitor for 15-30 minutes post-deployment

  4. Ambulation timing:

    • Manual compression: 18-22 hours bed rest
    • Successful ACD: 4-6 hours bed rest

The evidence consistently demonstrates that properly deployed ACDs reduce time to hemostasis and ambulation while maintaining or improving safety profiles compared to manual compression 1, 2.

References

Related Questions

In a 9‑week‑old infant with subfebrile temperature (maximum 37.8 °C), rhinorrhea, cough, a single post‑cough vomiting episode, inconsolable crying with transient abdominal tenderness that resolves when the infant stops crying, and normal stooling, what is the best management approach?
Are there lymph nodes located on the flank above the hip?
What is the appropriate treatment for a 25‑year‑old woman with malodorous leukorrhea?
What is the appropriate workup and treatment for a 75-year-old woman with acute swollen fingers limiting movement?
How should a public health audit be performed for a patient’s epidemiologic event to determine its origin, cause, and effect?
In a patient with systemic lupus erythematosus presenting with hemoptysis, what is the most urgent diagnosis and recommended management?
In bacterial pneumonia, is tigecycline preferred over linezolid?
What is the most likely cause and recommended management for exertional chest pain radiating to the left arm with throat burning and left‑arm paresthesia that occurs only when walking uphill, given that cardiac causes, pulmonary embolism, and imaging studies are normal?
What bacteria, besides methicillin‑resistant Staphylococcus aureus (MRSA), are susceptible to tigecycline?
Is diaphragmatic (abdominal) breathing normal in a 9-year-old child?
What is the recommended way to increase fetal hemoglobin in a three‑year‑old child with sickle cell disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.